Answers are grounded in this paper and cite their sources.
Biosynthesis of antioxidant nanoparticles using plant extracts is a simple, rapid, environmentally friendly, and cost-effective approach. In this study, in vitro antioxidant copper mixed oxide nanoparticles (CuO/Cu 2 O) were prepared from the alcoholic extract of Phoenix Dactylifera L. and different aqueous concentrations of CuSO 4 ·5H 2 O. The composition, crystallinity, morphology, and particle size of CuO/Cu 2 O NPs were tuned by increasing the CuSO 4 ·5H 2 O concentration from 4 to 10 mM. Ultraviolet–visible (UV–Vis) and Fourier-transform infrared (FTIR) spectroscopy confirmed the reduction of CuSO 4 ·5H 2 O and the formation of the CuO/Cu 2 O NPs. X-ray diffraction (XRD) confirmed the crystalline nature of the CuO/Cu 2 O NPs with a crystallite size varying from 18 to 35 nm. Scanning electron micrographs (SEM) showed that the CuO/Cu 2 O NPs have a spherical morphology with particle sizes ranging from 25 to 100 nm. The best antioxidant CuO/Cu 2 O NPs have a phase ratio of about 1:1 CuO/Cu 2 O with a half-maximal inhibitory concentration (IC 50 ) of 0.39 mg/ml, an iron-containing reducing antioxidant power (FRAP) of 432 mg EFeSO 4 /100 mg NPs, and a total antioxidant capacity (TAC) of 65 mg EAA/gNPs. The results suggest that the synthesized CuO/Cu 2 O NPs are excellent antioxidants for therapeutic applications.
No takes yet. Share an insight, caveat, or question.
Berra et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: